Yung Lyou

Someone used DALL-E to create gobbledygook scientific figures and submitted them to Frontiers Journal. And guess what? The editor published it. LOL frontiersin.org/articles/10.33…

@JackWestMD @Summitplc Congratulations! Best wishes on your next endeavor!

🚨 Big changes afoot! I'm proud to announce that I've joined Summit Therapeutics (@Summitplc) as VP of Clinical Development! I look forward to my colleagues learning more about the company & ivonescimab. No more commentary from me on new data, but I'll contribute as I can.

@montypal @cityofhope Congratulations!

Excited to announce that I have taken on the role of Vice Chair of Academic Affairs in the Department of Medical Oncology & Experimental Therapeutics at @cityofhope. Candidly, in my 17 years at this great institution, I’ve been reluctant to take on roles in leadership. Why? Well, I’ve just been so happy doing what I’m doing - seeing patients, doing research & working with phenomenal trainees and junior faculty. I view this new role as an opportunity for me to build on that third area of focus — my goal is to materialize the vision that each one of our faculty members has for their own career. I welcome any & all advice on how to accomplish this!

@Dr_Jen_Linehan Unfortunately I don’t think the authors conclusions are justified for the above reasons.

@Dr_Jen_Linehan It’s thought provoking but there’s so many flaws in this study.

This is fascinating- especially because cannabis use has definitely increased in cancer patients.

@chadinabhan Thanks for hosting this debate @chadinabhan! I appreciate you and @AaronGoodman33 giving voice to us on how us physicians truly feel about MOC.

I have always attempted to bring two people with opposing views to the same topic so that we debate the issue. This is the first time I wasn’t able to find ONE physician who would defend the MOC & recertification & I mentioned that point on the podcast. podcasts.apple.com/us/podcast/hea…

@AaronGoodman33 @chadinabhan Thanks for starting this petition and giving voice to our concerns!

Just signed. Thank you for starting this @AaronGoodman33! I also forwarded to all my physician colleagues to sign.

@DrZoffness You did the right thing. Not reporting and leading to more harm later would be much much worse. Being fired has happened to me too when patients disagree with my medical recommendations. I wouldn’t take it personally.

16 y/o pt using a sugar daddy website to meet older men to obtain booze & pills in exchange for sex. Parents knew. When asked, rated their concern a 2/10 😳 (Me? 11.) I'm a mandated reporter. They fired me & threatened to sue. 😔 What would you do? #psychtwitter #MedTwitter

@montypal @kimi_uro @Keio_Univ @cityofhope @ASCO @ASCOPres @CliffordHudis @DrEricWiner @DrChoueiri @neerajaiims @ERPlimackMD @VivekSubbiah @IshwariaMD @drdonsdizon @chana_weinstock That’s so cute of your daughter to do that for him! Congrats on your Lancet publication also!

(1/2) Excited to host @kimi_uro from @Keio_Univ at @cityofhope as a part of the @ASCO/#JSCO collaboration! Enjoyed introducing him to many outstanding colleagues at #ASCO23. He will be staying at my home - most excited about this is my 9 yo daughter who …

@Dr_Jen_Linehan @CancerSupportLA @ProvCalifornia @SaintJohnsCI @saintjohnsheals Congratulations!

An honor of a lifetime! @CancerSupportLA thank you for all the support and love! @ProvCalifornia @SaintJohnsCI @saintjohnsheals

Google Bard is amazing for translating medical diseases into Korean. As a hematologist who speaks Korean im impressed! Prompt: “Explain acute ITP in Korean.” #googlebard #medicaltranslation

Congratulations to 2023 MCR Michael B. Kastan Award for Research Excellence winner @marian_waterman! Read the award-winning article from @g_chen, Dr. Waterman et al. detailing how Wnt signaling disruption can promote #ColorectalCancer invasion— bit.ly/3UIyckD #AACR23

@ZeynepZengin @TDorffOnc @montypal @DrRaviSalgia @cityofhope @CityofHope_GU @arafflemd @AdamBraunMD @Kanurkkoooo @LuisMezaco @NazliDizman @crisbergerot @neerajaiims @AbhiTrip87 Congratulations Tanya!

Can’t think anyone who deserves this more than @TDorffOnc! Congrats on making full professor!!🥂 @montypal @DrRaviSalgia @cityofhope @CityofHope_Gu

@montypal @cityofhope @ZeynepZengin @LuisMezaco @YaleIMed @NazliDizman @DrRaviSalgia @Yale @ERPlimackMD @VivekSubbiah @DrChoueiri @PGrivasMDPhD @NehaVapiwala @CharuAggarwalMD @rachnatshroff @YJanjigianMD Wow! Congratulations!

Words cannot express how proud I am of my @cityofhope fellows @ZeynepZengin 🇹🇷 & @LuisMezaco 🇵🇪, who matched at @YaleIMed just moments ago (yes, I am wearing a #YaleDad hat!). Their hard work & dedication over 3y has paid off. Huge thanks to @NazliDizman for blazing this trail & @MarkDSiegel1 for giving these terrific international scholars a pathway into #academia. With @ASCOPres @PamelaKunzMD @BraunMDPhD @DrRoyHerbstYale @DanielPetrylak @Dr_AmerZeidan & so many other leaders in #oncology at @YaleCancer, tremendous opportunities for #mentorship! @ASCO @myESMO @SWOG @ConquerCancerFd @MOASC_Office

@RohanGarjeMD @ASCO @JCOOP_ASCO @thomashopemd @BryanRumble @BrainTumorDoc @BaptistHealthSF @neerajaiims @montypal @BHCancerCare @UIowaCancer @DrScottTagawa @JCO_ASCO Great article! What are your thoughts on patients who have bone marrow infiltration?

🆕Publication: Q&A on @ASCO guideline on 177 Lutetium PSMA for #prostatecancer @JCOOP_ASCO ➡️ provides guidance on patient selection, utility of Ga-68 & Piflufolastat PSMA scans, response assessment, and emphasizes multidisciplinary collaboration. ▶️ascopubs.org/doi/full/10.12…

Just In @KCA_Journal: Excellent review on the current clinical trials & future directions in CAR T-cell Rx in renal cell carcinoma #KidneyCancer by @YungLyou & @TDorffOnc👉bit.ly/3FrZRiv👉Promising therapeutic potential @OncoAlert @providence @CityofHope_GU @kidneycan

@DavidBenjaminMD @UofCAHealth @JTOonline @IASLC @MattGubensMD @ViolaWZhu @karenkellymd @EGFRResisters @ros1cancer @StephenVLiu @DrJNaidoo @JackWestMD @LungCancerFaces Congratulations and great work!

Pleased to share our @UofCAHealth study on adding immunotherapy to chemotherapy in oncogenic driven #NSCLC now in @JTOonline Clinical and Research Reports. Regardless of driver mutation, we found no survival benefit with adding ICI to chemotherapy. Link: jtocrr.org/article/S2666-…

@NazliDizman @MDAndersonNews @montypal @DrChoueiri @JenWargoMD @OncHahn @PavlosMsaouel @PGrivasMDPhD @neerajaiims @NarjustFlorezMD @MarkDSiegel1 @YaleIMed @DelaCruzYaleMed Wow! Congratulations!

🥳Thrilled to share that I'm going to @MDAndersonNews for Heme/Onc fellowship!! Forever grateful for my family, #BestMentorEver @montypal, many mentors/sponsors & friends who supported me along the way🙏 Can't wait to become an official member of the #Oncology community!